| Model Number |
6900P |
| Medical Device Problem Codes |
Gradient Increase (1270); Insufficient Device Problem Information (3190)
|
| Health Effect - Clinical Codes |
Heart Failure/Congestive Heart Failure (4446); Insufficient Information (4580)
|
| Date of Event |
11/29/2022
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
The device was not returned to edwards for evaluation as it remains implanted.Attempts to retrieve additional information is in process.The investigation is still in progress.Therefore; a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
| |
|
Event or Problem Description
|
|
Edwards received information a patient with an unknown edwards surgical valve implanted for an unknown implant duration underwent valve-in-valve procedure due to unknown reasons.A 29mm 9600tfx transcatheter valve was successfully implanted inside the surgical valve.
|
| |
|
Additional Manufacturer Narrative
|
|
The device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections prior to release for distribution.Stenosis, which develops progressively over time, can be due to a number of issues.Additionally, there can be a number of potential known and unknown patient-related contributing factors.Structural valve deterioration (svd) is the most common reason for bioprosthesis explant and encompasses multiple failure modes, including calcification, noncalcific degeneration, dehiscence, cusp thickening or fibrosis, or a combination of these.Such failure modes, occurring singularly or concomitantly, may contribute to stenosis and/or regurgitation.Alternatively, non-structural valve dysfunction (nsvd) may also play a role in the development of valvular stenosis.Stenosis is most commonly related to patient factors and is not usually an indication of a device malfunction.A definitive root cause cannot be conclusively determined; however, patient and/or procedural factors likely caused or contributed.
|
| |
|
Event or Problem Description
|
|
It was learned that a patient with a 29mm 6900p mitral valve underwent a valve-in-valve procedure after an implant duration of 4 years, 8 months due to stenosis.The patient presented with hf and sob.The tmvr was performed with a 29mm 9600tfx transcatheter valve.The patient expired on pod #17.
|
| |
|
Additional Manufacturer Narrative
|
|
The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.
|
| |
|
Search Alerts/Recalls
|